Mechanisms of anabolic therapies for osteoporosis

N Engl J Med. 2007 Aug 30;357(9):905-16. doi: 10.1056/NEJMra067395.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anabolic Agents / therapeutic use*
  • Bone Density / drug effects
  • Bone Density / physiology
  • Bone Density Conservation Agents / therapeutic use*
  • Bone Morphogenetic Proteins / physiology
  • Bone Remodeling / drug effects
  • Bone Remodeling / physiology*
  • Female
  • Humans
  • Insulin-Like Growth Factor I / physiology
  • Male
  • Osteoporosis / drug therapy*
  • Osteoporosis / physiopathology
  • Parathyroid Hormone / administration & dosage*
  • Teriparatide / therapeutic use
  • Wnt Proteins / antagonists & inhibitors
  • Wnt Proteins / physiology

Substances

  • Anabolic Agents
  • Bone Density Conservation Agents
  • Bone Morphogenetic Proteins
  • Parathyroid Hormone
  • Wnt Proteins
  • Teriparatide
  • Insulin-Like Growth Factor I